222 related articles for article (PubMed ID: 33901215)
1. High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
Deiss R; Loreti CV; Gutierrez AG; Filipe E; Tatia M; Issufo S; Ciglenecki I; Loarec A; Vivaldo H; Barra C; Siufi C; Molfino L; Tamayo Antabak N
PLoS One; 2021; 16(4):e0250195. PubMed ID: 33901215
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia.
Alemu AS; Kempker RR; Tenna A; Smitson C; Berhe N; Fekade D; Blumberg HM; Aseffa A
PLoS One; 2013; 8(3):e58377. PubMed ID: 23469276
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence and factors associated with cryptococcal antigenemia in HIV-infected patients in Cotonou/Benin].
Ogouyèmi-Hounto A; Zannou DM; Ayihounton G; Ahouada C; Azon-Kouanou A; Acakpo J; Sissinto Savi de Tove Y; Kinde Gazard D
J Mycol Med; 2016 Dec; 26(4):391-397. PubMed ID: 27641486
[TBL] [Abstract][Full Text] [Related]
4. Preventing deaths from cryptococcal meningitis: from bench to bedside.
Roy M; Chiller T
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
[TBL] [Abstract][Full Text] [Related]
5. Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.
Chisale MRO; Jordan A; Kamudumuli PS; Mvula B; Odo M; Maida A; Kandulu J; Chilima B; Sinyiza FW; Katundu P; Lee HY; Mtegha R; Wu TJ; Bitirinyo J; Nyirenda R; Kalua T; Greene G; Chiller T
PLoS One; 2023; 18(5):e0284367. PubMed ID: 37141243
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
Oyella J; Meya D; Bajunirwe F; Kamya MR
J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
[TBL] [Abstract][Full Text] [Related]
10. Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.
Kwan CK; Leelawiwat W; Intalapaporn P; Anekthananon T; Raengsakulrach B; Peters PJ; McNicholl JM; Park BJ; McConnell MS; Weidle PJ
J Int Assoc Provid AIDS Care; 2014; 13(5):434-7. PubMed ID: 24003059
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.
Derbie A; Mekonnen D; Woldeamanuel Y; Abebe T
BMC Infect Dis; 2020 Jun; 20(1):407. PubMed ID: 32527231
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil.
Ferreira MF; Brito-Santos F; Trilles L; Almeida MA; Wanke B; Veloso VG; Nunes EP; Lazera MDS
Mycoses; 2020 Feb; 63(2):145-150. PubMed ID: 31715053
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort.
Patel S; Shin GY; Wijewardana I; Vitharana SR; Cormack I; Pakianathan M; Harrison TS; Bicanic T
J Infect; 2013 Jan; 66(1):75-9. PubMed ID: 23046967
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal antigen carriage among HIV infected children aged 6 months to 15 years at Laquintinie Hospital in Douala.
Kalla GCM; Mboumnyemb JF; Assob JCN; Ehouzou Mandeng MN; Kamgaing Noubi N; Okomo Assoumou MC; Mbopi-Keou FX; Monebenimp F
PLoS One; 2021; 16(7):e0253781. PubMed ID: 34242263
[TBL] [Abstract][Full Text] [Related]
20. Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau.
Thomsen D; Hviid CJ; Hønge BL; Medina C; Té DDS; Correira FG; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Jespersen S
Pan Afr Med J; 2018; 29():18. PubMed ID: 29662603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
